59MDWI48-107 governs the management and reporting of communicable and other reportable diseases.
View 59MDWI48-107 on armypubs.army.mil
It addresses sexually transmitted infections, HIV, rabies, and tuberculosis, with STI detection, treatment, education, screening, surveillance, and contact investigations. It requires clinical follow-up, laboratory notifications, reporting, and testing or treatment actions under CDC guidelines.
Applies to: This instruction applies to all personnel assigned, attached, or on contract to the 59th Medical Wing (MDW) with the exception of 959th Medical Group (MDG).
The purpose of the STI Program is to detect, treat and provide education to patients infected with STIs in order to break the chain of infection and prevent complications and/or chronic disease.
Clinically track pending laboratory tests and notify patients of positive STI results within 72 hours of the lab resulting.
Instruct patients to avoid intimate contact and/or sexual intercourse until 7 days after a single-dose regimen or after completion of a 7-day regimen for themselves AND for their contact(s).
Providers who diagnose and treat patients with an STI, as well as Public Health staff who provide follow-up counselling, will advise each patient of the need for follow-up testing 90 days later.
Test and treat STI contacts presumptively IAW CDC treatment guidelines.